BSW Wealth Partners lessened its stake in The Cigna Group (NYSE:CI – Free Report) by 25.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,078 shares of the health services provider’s stock after selling 368 shares during the period. BSW Wealth Partners’ holdings in The Cigna Group were worth $298,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in CI. IFG Advisors LLC lifted its holdings in shares of The Cigna Group by 4.6% in the 3rd quarter. IFG Advisors LLC now owns 699 shares of the health services provider’s stock worth $242,000 after acquiring an additional 31 shares during the last quarter. McClarren Financial Advisors Inc. boosted its position in The Cigna Group by 4.7% during the third quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider’s stock valued at $240,000 after buying an additional 31 shares during the period. Castle Rock Wealth Management LLC grew its stake in shares of The Cigna Group by 0.5% during the third quarter. Castle Rock Wealth Management LLC now owns 6,651 shares of the health services provider’s stock valued at $2,263,000 after buying an additional 34 shares during the last quarter. Adero Partners LLC increased its holdings in shares of The Cigna Group by 4.5% in the third quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock worth $273,000 after buying an additional 34 shares during the period. Finally, Waldron Private Wealth LLC lifted its stake in shares of The Cigna Group by 1.0% in the 3rd quarter. Waldron Private Wealth LLC now owns 3,651 shares of the health services provider’s stock valued at $1,265,000 after acquiring an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have commented on CI shares. Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 price target (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Barclays increased their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a report on Monday, November 4th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $395.93.
The Cigna Group Price Performance
CI opened at $303.49 on Thursday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The company has a market cap of $84.42 billion, a price-to-earnings ratio of 28.63, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The stock has a fifty day simple moving average of $296.45 and a two-hundred day simple moving average of $325.14. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.
The Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. During the same period last year, the business earned $6.77 EPS. The Cigna Group’s quarterly revenue was up 29.8% compared to the same quarter last year. Research analysts predict that The Cigna Group will post 28.5 earnings per share for the current fiscal year.
The Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than The Cigna Group
- What is a Secondary Public Offering? What Investors Need to Know
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- How to Invest in Insurance Companies: A Guide
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.